Ryan Phillips, MD, PhD, on Observation or Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer?

Posted: Monday, September 30, 2019

Ryan Phillips, MD, PhD, of Johns Hopkins Medical Institutions, discusses which patients with oligometastatic prostate cancer might benefit from stereotactic ablative radiation therapy, given the results of the ORIOLE trial.